Proton pump inhibitors alter the composition of the gut microbiota

OBJECTIVE: Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production and treat GI disorders such as peptic ulcers and gastro-oesophageal reflux. They have been considered low risk, have been widely adopted, and are often over-prescribed. Recent studies have identified an incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Matthew A, Goodrich, Julia K, Maxan, Maria-Emanuela, Freedberg, Daniel E, Abrams, Julian A, Poole, Angela C, Sutter, Jessica L, Welter, Daphne, Ley, Ruth E, Bell, Jordana T, Spector, Tim D, Steves, Claire J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Gut Microbiota
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853574/
https://www.ncbi.nlm.nih.gov/pubmed/26719299
http://dx.doi.org/10.1136/gutjnl-2015-310861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853574/
https://www.ncbi.nlm.nih.gov/pubmed/26719299
http://dx.doi.org/10.1136/gutjnl-2015-310861

Ejemplares similares